Works matching IS 15901874 AND DT 2011 AND VI 31

Results: 10

Efficacy and tolerability of natalizumab in relapsing-remitting multiple sclerosis patients: a post-marketing observational study.

Published in:

Neurological Sciences, 2011, v. 31, p. 299, doi. 10.1007/s10072-010-0344-z

By:

Sangalli, F.;
Moiola, L.;
Bucello, S.;
Annovazzi, P.;
Rizzo, A.;
Radaelli, M.;
Vitello, G.;
Grimaldi, L.;
Ghezzi, A.;
Martinelli, V.;
Comi, G.

Publication type:

Article

Natalizumab efficacy on cognitive impairment in MS.

Published in:

Neurological Sciences, 2011, v. 31, p. 321, doi. 10.1007/s10072-010-0351-0

By:

Mattioli, F.;
Stampatori, C.;
Bellomi, F.;
Capra, R.

Publication type:

Article

Natalizumab treatment in multiple sclerosis: the experience of S. Andrea MS Centre in Rome.

Published in:

Neurological Sciences, 2011, v. 31, p. 303, doi. 10.1007/s10072-010-0348-8

By:

Prosperini, L.;
Borriello, G.;
Fubelli, F.;
Marinelli, F.;
Pozzilli, Carlo

Publication type:

Article

Natalizumab prevents the accumulation of cortical lesions in relapsing remitting multiple sclerosis: a preliminary report.

Published in:

Neurological Sciences, 2011, v. 31, p. 317, doi. 10.1007/s10072-010-0346-x

By:

Rinaldi, F.;
Calabrese, M.;
Seppi, D.;
Puthenparampil, M.;
Perini, P.;
Gallo, P.

Publication type:

Article

Improvement of visual acuity in patients with severe visual loss affected by multiple sclerosis treated with natalizumab: a case report.

Published in:

Neurological Sciences, 2011, v. 31, p. 325, doi. 10.1007/s10072-010-0349-7

By:

Florio, Ciro;
Maniscalco, Giorgia

Publication type:

Article

Three years of experience: the Italian registry and safety data update.

Published in:

Neurological Sciences, 2011, v. 31, p. 295, doi. 10.1007/s10072-010-0356-8

By:

Mancardi, G.;
Tedeschi, G.;
Amato, M.;
D'Alessandro, R.;
Drago, F.;
Milanese, C.;
Popoli, P.;
Rossi, P.;
Savettieri, G.;
Tola, M.;
Comi, G.;
Pozzilli, C.;
Bertolotto, A.;
Marrosu, M.;
Grimaldi, L.;
Laroni, A.;
Vanacore, N.;
Covezzoli, A.;
Rosa, M.;
Piccinni, C.

Publication type:

Article

The cohort of the multiple sclerosis center of Cagliari.

Published in:

Neurological Sciences, 2011, v. 31, p. 309, doi. 10.1007/s10072-010-0470-7

By:

Marrosu, M.;
Lorefice, L.;
Frau, J.;
Coghe, G.;
Fenu, G.;
Piras, R.;
Melis, M.;
Cocco, E.

Publication type:

Article

Swedish natalizumab (Tysabri) multiple sclerosis surveillance study.

Published in:

Neurological Sciences, 2011, v. 31, p. 289, doi. 10.1007/s10072-010-0345-y

By:

Piehl, Fredrik;
Holmén, C.;
Hillert, J.;
Olsson, T.

Publication type:

Article

Natalizumab: state of the art and open questions.

Published in:

Neurological Sciences, 2011, v. 31, p. 313, doi. 10.1007/s10072-010-0430-2

By:

Comi, G.

Publication type:

Article

The advent of monoclonal antibodies in the treatment of chronic autoimmune diseases.

Published in:

Neurological Sciences, 2011, v. 31, p. 283, doi. 10.1007/s10072-010-0382-6

By:

Bruno, Valeria;
Battaglia, Giuseppe;
Nicoletti, Ferdinando

Publication type:

Article